Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in boston keratoprosthesis type 1

Cornea

Volumn 33, Issue 9, 2014, Pages 914-918

  Kanellopoulos, Anastasios J ^a,b   Asimellis, George ^a  

^a Laservisiongr Eye Institute   (Greece)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Boston keratoprosthesis type 1; chemical burn; Dohlman keratoprosthesis; ocular cicatricial pemphigoid; prophylactic pretreatment with collagen crosslinking; repeat cornea transplantation failure; severe external disease

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE; COLLAGEN; CROSS LINKING REAGENT; PHOTOSENSITIZING AGENT; RIBOFLAVIN;

AGED; ARTICLE; BOSTON KERATOPROSTHESIS TYPE 1; CLINICAL ARTICLE; CORNEA SURGERY; CORNEA TRANSPLANTATION; FEMALE; FOLLOW UP; HIGH FLUENCE COLLAGEN CROSSLINKING; HUMAN; KERATOPROSTHESIS; MALE; PRIORITY JOURNAL; VISUAL ACUITY; BIOPROSTHESIS; CORNEA; CORNEA STROMA; CORNEAL DISEASES; DONOR; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; ULTRAVIOLET RADIATION;

AGED; BIOPROSTHESIS; COLLAGEN; CORNEA; CORNEAL DISEASES; CORNEAL STROMA; CROSS-LINKING REAGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PHOTOSENSITIZING AGENTS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RIBOFLAVIN; TISSUE DONORS; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 84905991390     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000176     Document Type: Article

References (28)

1. Cruzat A, Shukla A, Dohlman CH, et al. Wound anatomy after type 1 Boston KPro using oversized back plates. Cornea. 2013;32:1531-1536.
2. Ziai S, Rootman DS, Slomovic AR, et al. Oral buccal mucous membrane allograft with a corneal lamellar graft for the repair of Boston type 1 keratoprosthesis stromal melts. Cornea. 2013;32:1516-1519.
3. Ciolino JB, Belin MW, Todani A, et al; Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2013;120:1195-1200.
4. Klufas MA, Colby KA. The Boston keratoprosthesis. Int Ophthalmol Clin. 2010;50:161-175.
5. Ngakeng V, Hauck MJ, Price MO, et al. AlphaCor keratoprosthesis: a novel approach to minimize the risks of long-term postoperative complications. Cornea. 2008;27:905-910.
6. Lim LS, Ang CL, Wong E, et al. Vitreoretinal complications and vitre-oretinal surgery in osteo-odonto-keratoprosthesis surgery. Am J Ophthal-mol. 2014;157:349-354.
7. Ghaffariyeh A, Honarpisheh N, Karkhaneh A, et al. Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts. Graefes Arch Clin Exp Ophthalmol. 2011;249: 93-101.
8. Kanellopoulos AJ. Post-LASIK ectasia. Ophthalmology. 2007;114:1230.
9. Kanellopoulos AJ, Pamel GJ. Review of current indications for combined very high fluence collagen cross-linking and laser in situ kerato-mileusis surgery. Indian J Ophthalmol. 2013;61:430-432.
10. Kanellopoulos AJ. Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg. 2009;25:1034-1037.
11. Krueger RR, Ramos-Esteban JC, Kanellopoulos AJ. Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous ker-atopathy: laboratory investigation and first clinical case. J Refract Surg. 2008;24:S730-S736.
12. Kanellopoulos AJ, Asimellis G. Anterior-segment optical coherence tomography investigation of corneal deturgescence and epithelial remodeling after DSAEK. Cornea. 2014;33:340-348.
13. Sakimoto T, Sawa M. Metalloproteinases in corneal diseases: degradation and processing. Cornea. 2012;31(suppl 1):S50-S56.
14. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96: 776-780.
15. Palioura S, Kim B, Dohlman CH, et al. The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea. 2013;32:956-961.
16. Kang JJ, Allemann N, Vajaranant T, et al. Anterior segment optical coherence tomography for the quantitative evaluation of the anterior segment following Boston keratoprosthesis. PLoS One. 2013;8:e70673.
17. Kim MJ, Yu F, Aldave AJ. Microbial keratitis after Boston type I ker-atoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology. 2013;120:2209-2216.
18. Robert MC, Eid EP, Saint-Antoine P, et al. Microbial colonization and antibacterial resistance patterns after Boston type 1 keratoprosthesis. Ophthalmology. 2013;120:1521-1528.
19. Robert MC, Pomerleau V, Harissi-Dagher M. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices. Br J Ophthalmol. 2013;97:573-577.
20. Sivaraman KR, Hou JH, Allemann N, et al. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston keratopros-thesis. Am J Ophthalmol. 2013;155:814-822.
21. Chan CC, Holland EJ. Infectious keratitis after Boston type 1 keratopros-thesis implantation. Cornea. 2012;31:1128-1134.
22. Utine CA, Tzu JH, Akpek EK. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt. Ocul Immunol Inflamm. 2011;19:413-418.
23. Feng MT, Burkhart ZN, McKee Y, et al. A technique to rescue kerato-prosthesis melts. Cornea. 2013. [epub ahead of print] (PMID: 23974889).
24. Adesina OO, Vickery JA, Ferguson CL, et al. Stromal melting associated with a cosmetic contact lens over a Boston keratoprosthesis: treatment with a conjunctival flap. Eye Contact Lens. 2013;39:e4-6.
25. Jordan C, Patel DV, Abeysekera N, et al. In vivo confocal microscopy analyses of corneal microstructural changes in a prospective study of collagen cross-linking in keratoconus. Ophthalmology. 2014;121: 469-474.
26. Tayapad JB, Viguilla AQ, Reyes JM. Collagen cross-linking and corneal infections. Curr Opin Ophthalmol. 2013;24:288-290.
27. Mencucci R, Marini M, Paladini I, et al. Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Experiment Ophthalmol. 2010;38:49-56.
28. Messmer EM, Meyer P, Herwig MC, et al. Morphological and immuno-histochemical changes after corneal cross-linking. Cornea. 2013;32: 111-117.